SRPT vs. VTV
SRPT (Sarepta Therapeutics, Inc.) is a stock, while VTV (Vanguard Value ETF) is Large Cap Value Equities fund tracking the CRSP US Large Cap Value Index. Over the past 10 years, SRPT returned -1.03%/yr vs 12.96%/yr for VTV. At a 0.30 correlation, their price movements are largely independent.
Performance
SRPT vs. VTV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SRPT achieves a -22.42% return, which is significantly lower than VTV's 14.56% return. Over the past 10 years, SRPT has underperformed VTV with an annualized return of -1.03%, while VTV has yielded a comparatively higher 12.96% annualized return.
SRPT
- 1D
- -3.27%
- 1M
- -0.63%
- YTD
- -22.42%
- 6M
- -25.20%
- 1Y
- -12.04%
- 3Y*
- -47.30%
- 5Y*
- -26.98%
- 10Y*
- -1.03%
VTV
- 1D
- 0.07%
- 1M
- 3.17%
- YTD
- 14.56%
- 6M
- 13.44%
- 1Y
- 26.34%
- 3Y*
- 18.69%
- 5Y*
- 12.10%
- 10Y*
- 12.96%
SRPT vs. VTV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics, Inc. | -22.42% | -82.30% | 26.09% | -25.58% | 43.90% | -47.18% | 32.12% | 18.24% | 96.14% | 102.84% |
VTV Vanguard Value ETF | 14.56% | 15.27% | 15.95% | 9.32% | -2.09% | 26.53% | 2.33% | 25.66% | -5.47% | 17.15% |
Correlation
The correlation between SRPT and VTV is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jan 30, 2004 | 0.30 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SRPT vs. VTV — Risk / Return Rank
SRPT
VTV
SRPT vs. VTV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and Vanguard Value ETF (VTV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SRPT | VTV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.68 | ||
| Sortino ratioReturn per unit of downside risk | -3.15 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.46 | -0.38 |
| Calmar ratioReturn relative to maximum drawdown | -0.26 | 4.17 | -4.43 |
| Martin ratioReturn relative to average drawdown | -0.58 | 15.70 | -16.28 |
Loading charts...
Drawdowns
SRPT vs. VTV - Drawdown Comparison
The maximum SRPT drawdown since its inception was -98.17%, which is greater than VTV's maximum drawdown of -59.27%. Use the drawdown chart below to compare losses from any high point for SRPT and VTV.
Loading charts...
Drawdown Indicators
| SRPT | VTV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.17% | -59.27% | -38.90% |
Max Drawdown (1Y)Largest decline over 1 year | -45.70% | -6.35% | -39.35% |
Max Drawdown (3Y)Largest decline over 3 years | -92.72% | -14.52% | -78.20% |
Max Drawdown (5Y)Largest decline over 5 years | -92.72% | -17.04% | -75.68% |
Max Drawdown (10Y)Largest decline over 10 years | -93.33% | -36.78% | -56.55% |
Current DrawdownCurrent decline from peak | -90.66% | -0.48% | -90.18% |
Average DrawdownAverage peak-to-trough decline | -68.19% | -7.85% | -60.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.73% | 1.68% | +19.05% |
Volatility
SRPT vs. VTV - Volatility Comparison
Sarepta Therapeutics, Inc. (SRPT) has a higher volatility of 16.33% compared to Vanguard Value ETF (VTV) at 3.33%. This indicates that SRPT's price experiences larger fluctuations and is considered to be riskier than VTV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SRPT | VTV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.33% | 3.33% | +13.00% |
Volatility (6M)Calculated over the trailing 6-month period | 52.61% | 7.85% | +44.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.99% | 10.38% | +83.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.86% | 13.87% | +55.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.36% | 16.64% | +53.72% |
Dividends
SRPT vs. VTV - Dividend Comparison
SRPT has not paid dividends to shareholders, while VTV's dividend yield for the trailing twelve months is around 1.83%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VTV Vanguard Value ETF | 1.83% | 2.05% | 2.31% | 2.46% | 2.52% | 2.15% | 2.56% | 2.50% | 2.73% | 2.29% | 2.44% | 2.60% |
Frequently Asked Questions
SRPT and VTV have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SRPT has higher volatility (16.33%) compared to VTV (3.33%). In terms of maximum drawdown, SRPT dropped -98.17% vs VTV's -59.27%.
VTV currently has the higher Sharpe Ratio (2.56 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SRPT and VTV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer